Reactogenicity and immunogenicity of a live attenuated tetravalent measles–mumps–rubella–varicella (MMRV) vaccine
- 1 December 2002
- Vol. 21 (3-4) , 281-289
- https://doi.org/10.1016/s0264-410x(02)00459-0
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Measles, Mumps, Rubella, and Varicella Combination Vaccine: Safety and Immunogenicity Alone and in Combination with Other Vaccines Given to ChildrenClinical Infectious Diseases, 1997
- Safety and Immunogenicity of a Combined Live Attenuated Measles, Mumps, Rubella, and Varicella Vaccine (MMRIIV) in Healthy ChildrenThe Journal of Infectious Diseases, 1996
- Seroconversion Rates to Combined Measles-Mumps-Rubella-Varicella Vaccine of Children With Upper Respiratory Tract InfectionPediatrics, 1994
- Combination vaccinesThe Pediatric Infectious Disease Journal, 1994
- Evaluation of Live Attenuated Varicella Vaccine (Oka‐RIT Strain) and Combined Varicella and MMR Vaccination in 13–17‐Month‐Old ChildrenActa Paediatrica, 1991
- Combined Vaccine Against Measles, Mumps, Rubella, and VaricellaPediatrics, 1988
- Interference between strains in live virus vaccines II: combined vaccination with varicella and measles-mumps-rubella vaccineJournal of Biological Standardization, 1988